DPP4 and type 2 diabetes mellitus: The EWH obtained via pepsin- and peptidase-mediated hydrolysis exhibits the maximum potential for MetS-related disorders such as hypertension, obesity and T2D, with IC50 values for DPP-IV and inhibition of <10 mg protein/mL and in the range of 47 to 151 μg/mL, respectively.